Abstract |
As a test of the efficacy of desipramine (DMI) in the treatment of cocaine dependence, 59 cocaine-dependent males, maintained on methadone for the treatment of opiate dependence, completed a 12-week, random-assignment, placebo-controlled trial of this medication. At the end of treatment, there were no overall differences between the placebo and DMI groups on a range of outcome measures, including urine toxicology tests. However, an interaction between psychiatric diagnosis and outcome was seen when the sample was divided into those with (51%) and those without (49%) antisocial personality disorder (ASP). Patients with ASP made few gains with either DMI or placebo. Those without ASP made a number of gains with DMI but not placebo, particularly in the areas of psychiatric symptoms, legal status, and family problems. DMI had a significant effect on the psychiatric symptoms and personal adjustment problems, but not the cocaine use, of non-antisocial cocaine abusers. The negative influence of ASP that has been seen in studies of psychosocial therapies for substance-use disorders may also apply to pharmacological therapies.
|
Authors | I O Arndt, A T McLellan, L Dorozynsky, G E Woody, C P O'Brien |
Journal | The Journal of nervous and mental disease
(J Nerv Ment Dis)
Vol. 182
Issue 3
Pg. 151-6
(Mar 1994)
ISSN: 0022-3018 [Print] United States |
PMID | 8113775
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Placebos
- Cocaine
- Desipramine
- Methadone
|
Topics |
- Adult
- Antisocial Personality Disorder
(complications, drug therapy, epidemiology)
- Cocaine
- Comorbidity
- Desipramine
(therapeutic use)
- Humans
- Male
- Methadone
(therapeutic use)
- Middle Aged
- Opioid-Related Disorders
(rehabilitation)
- Personality Inventory
- Placebos
- Psychiatric Status Rating Scales
- Severity of Illness Index
- Substance-Related Disorders
(drug therapy, epidemiology, rehabilitation)
- Treatment Outcome
|